Collection 專利 [0/18] 期刊論文 [157/157] 會議論文/會議摘要 [23/37] Siblings 伍素瑩 [52/65] 其他 [58/60] 夏克山 [76/98] 岳嶽 [29/32] 張仲明 [7/9] 張俊彥 [18/18] 張竣評 [21/26] 徐祖安 [170/215] 李秀珠 [75/105] 李靜琪 [23/24] 林書玉 [19/20] 洪明秀 [31/40] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [35/39] 童俊維 [23/23] 紀雅惠 [21/25] 翁紹華 [22/24] 莊宏 [1/1] 葉修華 [24/25] 葉燈光 [133/152] 蔣維棠 [41/66] 謝興邦 [171/231] 趙宇生(2002-2013) [120/212] 郭靜娟 [49/55] 鄒倫 [28/29] 陳志豪 [31/52] 陳新(2002-2015) [53/67] 顏婉菁 [6/7] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] Community Statistics 近3年內發表的文件:19(8.96%) 含全文筆數:180(84.91%) 文件下載次數統計 下載大於0次:180(100.00%) 下載大於100次:176(97.78%) 檔案下載總次數:97059(1.81%) 最後更新時間: 2024-11-28 08:02 Top Upload Loading... Top Download Loading... Recent Submissions DBPR116, a prodrug of BPRMU191, in ... Discovery of a mu-opioid receptor m... Discovery of a long half-life AURKA... Postfermented tea extract potently ... Natural fucoidans inhibit coronavir... Development of furanopyrimidine-bas... The synergistic inhibition of coron... Omicron-specific mRNA vaccine induc... BPR0C261, an analogous of microtubu... Protective effect of CXCR4 antagoni...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 176-200 of 212. (9 Page(s) Totally) << < 1 2 3 4 5 6 7 8 9 > >> View [10|25|50] records per page

Date	Title	Relation
2007-03-14	Novel nanoparticles for oral insulin delivery via the paracellular pathway	Nanotechnology. 2007 Mar;18(10):Article number 105102.
2007-03-01	3-[2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-butyramide analogues as selective DPP-IV inhibitors for the treatment of type-II diabetes	Bioorganic and Medicinal Chemistry Letters. 2007 Mar;17(5):1274-1279.
2007-03	Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas	Journal of Biomedical Science. 2007 Mar;14(2):233-244.
2007-02-01	Development and validation of a liquid chromatography-tandem mass spectrometry for the determination of BPR0L075, a novel antimicrotuble agent, in rat plasma: Application to a pharmacokinetic study	Journal of Chromatography B. 2007 Feb;846(1-2):162-168.
2007-01	Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery	Biomacromolecules. 2007 Jan;8(1):146-152.
2006-12	Pharmacokinetics of anti-SARS-CoV agent niclosamide and its analogs in rats	Journal of Food and Drug Analysis. 2006 Dec;14(4):329-333.
2006-11-25	The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes	Life Sciences. 2006 Nov;79(26):2432-2440.
2006-10-31	Imidazolidinone compounds	US7129359B2/2006-10-31
2006-09-19	Imidazolamino compounds	US7109227B2/2006-09-19
2006-09	MEDI 416-3- 2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino -3-methyl-butyr amide analogs as DPP-IV inhibitors for the treatment of type-II diabetes	Abstracts of Papers - American Chemical Society. 2006 Sep;232:MEDI 416.
2006-08	Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control	Journal of Clinical Endocrinology and Metabolism. 2006 Aug;91(8):3084-3087.
2006-07	Non-lethal Candida albicans cph1/cph1 efg1/efg1 transcription factor mutant establishing restricted zone of infection in a mouse model of systemic infection	International Journal of Immunopathology and Pharmacology. 2006 Jul-Sep;19(3):561-565.
2006-06-15	Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors	Bioorganic and Medicinal Chemistry Letters. 2006 Jun;16(12):3268-3272.
2006-05-04	Structure-based drug design of a novel family of PPAR gamma partial agonists: Virtual screening, X-ray crystallography, and in vitro/in vivo biological activities	Journal of Medicinal Chemistry. 2006 May;49(9):2703-2712.
2006-03	Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer	Biomaterials. 2006 Mar;27(9):2051-2059.
2006-03	Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system against cultured HepG2 cells	Bioconjugate Chemistry. 2006 Mar;17(2):291-299.
2006-01-12	2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,2,3,4-tetrahydroisoquinoline: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV	Journal of Medicinal Chemistry. 2006 Jan;49(1):373-380.
2005-12-29	Novel indole-based peroxisome proliferator-activated receptor agonists: Design, SAR, structural biology, and biological activities	Journal of Medicinal Chemistry. 2005 Dec;48(26):8194-8208.
2005-06-07	Indol-3-YL-2-oxoacetamide compounds and methods of use thereof	US6903104B2/2005-06-07
2005-05	Loading of a novel angiogenic agent, ginsenoside Rg(1) in an acellular biological tissue for tissue regeneration	Tissue Engineering. 2005 May;11(5-6):835-846.
2005-04	A natural compound (ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration	Pharmaceutical Research. 2005 Apr;22(4):636-646.
2005-03-01	一種用以抑制癌細胞之醫藥組合物	I228417/2005-03-01
2005-03	Preparation of nanoparticles composed of chitosan/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells	Biomacromolecules. 2005 Mar;6(2):1104-1112.
2005-03	Design, synthesis and sar of indole-based PPAR agonists	Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U141.
2005-03	Design and structure-activity relationships of novel indole-based PPAR agonists as antidiabetic agents	Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U141.

Showing items 176-200 of 212. (9 Page(s) Totally) << < 1 2 3 4 5 6 7 8 9 > >> View [10|25|50] records per page